JP2023548005A5 - - Google Patents
Info
- Publication number
- JP2023548005A5 JP2023548005A5 JP2023521103A JP2023521103A JP2023548005A5 JP 2023548005 A5 JP2023548005 A5 JP 2023548005A5 JP 2023521103 A JP2023521103 A JP 2023521103A JP 2023521103 A JP2023521103 A JP 2023521103A JP 2023548005 A5 JP2023548005 A5 JP 2023548005A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- chain variable
- antibody
- antigen
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063106855P | 2020-10-28 | 2020-10-28 | |
| US202063106853P | 2020-10-28 | 2020-10-28 | |
| US63/106,855 | 2020-10-28 | ||
| US63/106,853 | 2020-10-28 | ||
| US202063122720P | 2020-12-08 | 2020-12-08 | |
| US63/122,720 | 2020-12-08 | ||
| PCT/US2021/057150 WO2022094152A1 (en) | 2020-10-28 | 2021-10-28 | Anti-transthyretin antibodies and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023548005A JP2023548005A (ja) | 2023-11-15 |
| JP2023548005A5 true JP2023548005A5 (enExample) | 2024-10-31 |
Family
ID=81384336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521103A Pending JP2023548005A (ja) | 2020-10-28 | 2021-10-28 | 抗トランスサイレチン抗体およびその使用方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230391859A1 (enExample) |
| EP (1) | EP4237005A4 (enExample) |
| JP (1) | JP2023548005A (enExample) |
| WO (1) | WO2022094152A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202434624A (zh) * | 2022-11-15 | 2024-09-01 | 瑞士商紐立慕公司 | 治療或預防甲狀腺素運載蛋白調節之澱粉樣變性的方法 |
| WO2024256583A1 (en) * | 2023-06-14 | 2024-12-19 | Immutrin Ltd | Anti-fibril antibodies |
| CN122374011A (zh) | 2023-12-15 | 2026-07-10 | 诺和诺德股份有限公司 | 稳定的液体制剂 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10213506B2 (en) * | 2014-08-26 | 2019-02-26 | University Of Tennessee Research Foundation | Targeting immunotherapy for amyloidosis |
| KR102410072B1 (ko) * | 2014-08-29 | 2022-06-20 | 알닐람 파마슈티칼스 인코포레이티드 | 트랜스타이레틴(ttr) 매개 아밀로이드증의 치료 방법 |
| TWI786505B (zh) * | 2015-01-28 | 2022-12-11 | 愛爾蘭商普羅佘納生物科技有限公司 | 抗甲狀腺素運送蛋白抗體 |
| LT3329002T (lt) * | 2015-07-31 | 2021-01-11 | Alnylam Pharmaceuticals, Inc. | Transtiretino (ttr) irnr kompozicijos ir jų naudojimo būdai, skirti naudoti su ttr susijusių ligų gydymui arba prevencijai |
| JP7017013B2 (ja) * | 2016-07-02 | 2022-02-08 | プロセナ バイオサイエンシーズ リミテッド | 抗トランスサイレチン抗体 |
| EP3478714A2 (en) * | 2016-07-02 | 2019-05-08 | Prothena Biosciences Limited | Anti-transthyretin antibodies |
| US11382974B2 (en) * | 2017-08-01 | 2022-07-12 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for treatment of amyloid deposition diseases |
| TWI904069B (zh) * | 2017-09-29 | 2025-11-11 | 美商英特利亞醫療公司 | 用於ttr基因編輯及治療attr澱粉樣變性之組合物及方法 |
| MA51223A (fr) * | 2017-11-29 | 2020-10-07 | Prothena Biosciences Ltd | Formulation lyophilisée d'un anticorps monoclonal contre la transthyrétine |
-
2021
- 2021-10-28 WO PCT/US2021/057150 patent/WO2022094152A1/en not_active Ceased
- 2021-10-28 EP EP21887569.8A patent/EP4237005A4/en active Pending
- 2021-10-28 JP JP2023521103A patent/JP2023548005A/ja active Pending
- 2021-10-28 US US18/033,568 patent/US20230391859A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020510646A5 (enExample) | ||
| JP2020002171A5 (enExample) | ||
| JP2023169297A5 (enExample) | ||
| IL319803A (en) | Methods and compositions for treating amyloid deposition diseases | |
| JP2021526534A5 (enExample) | ||
| JP2020002172A5 (enExample) | ||
| JP2018535948A5 (enExample) | ||
| RU2012140447A (ru) | Антиангиогенная терапия для лечения рака яичника | |
| JP2010502708A5 (enExample) | ||
| JP2020526553A5 (enExample) | ||
| JP2022513386A5 (enExample) | ||
| JP2024069230A5 (enExample) | ||
| JP2024038034A5 (enExample) | ||
| JP2021510523A5 (enExample) | ||
| JP2025514978A5 (enExample) | ||
| JP2022520107A5 (enExample) | ||
| JP2022529929A5 (enExample) | ||
| JP2018532693A5 (enExample) | ||
| JP2022553041A5 (enExample) | ||
| JP2023537078A5 (enExample) | ||
| JP2023548005A (ja) | 抗トランスサイレチン抗体およびその使用方法 | |
| JP2023506779A5 (enExample) | ||
| JP2009538916A5 (enExample) | ||
| JP2022514381A5 (enExample) | ||
| JP2024540294A5 (enExample) |